Discovery of 5-sulfonyltetrazoles as neuroblastoma differentiation agents is a research paper published in Bioorganic & Medicinal Chemistry Letters (2023). On theSindex it has a DataRank of 0. It has been cited 2 times.
Scored on demand from live citation data
DataRank reads this dataset's downstream impact straight off the citation graph β no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full β never from an abstract alone.
National Institutes of Health
Grant: 1R15CA213199-01A1
Discovery of New Differentiation Agents for Neuroblastoma Therapy
National Institutes of Health
Grant: 1R15CA227680-01A1
Acid-Sensitive Glioblastoma Prodrugs Derived from Ophiobolin A
NCI NIH HHS
Grant: R15 CA213199
NCI NIH HHS
Grant: R15 CA227680
NIGMS NIH HHS
Grant: R25 GM102783
FWCI
0.31
Citation Percentile
0.6%
Citation Trend
Fields of Study
MeSH Terms
Keywords